Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
1.25 USD +6.84% Intraday chart for Accelerate Diagnostics, Inc. -14.97% -68.11%
May. 20 Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust CI
May. 08 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust
CI
Accelerate Diagnostics: Q1 Earnings Snapshot
AQ
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M
MT
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
PR
Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Accelerate Diagnostics, Inc., Q1 2024 Earnings Call, May 08, 2024
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
PR
Accelerate Diagnostics : Failure to Satisfy Listing Rule - Form 8-K
PU
Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
PU
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
PR
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
AQ
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
PR
Top Midday Decliners
MT
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. News Accelerate Diagnostics, Inc.